(July 27, 2018, 2:33 PM EDT) -- CHICAGO — The Illinois federal judge presiding over the testosterone replacement therapy multidistrict litigation on July 26 denied a motion by a health insurer to certify a national and Ohio class of third-party payers who paid for the off-label prescription of testosterone drugs (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, Medical Mutual of Ohio, et al. v. AbbVie, Inc., et al., No. 14-8857, N.D. Ill., Eastern Div., 2018 U.S. Dist. LEXIS 125041)....